SomaGenics, Inc. is a privately held biotech company based in Santa Cruz, CA. Specializing in small RNA technologies, the company focuses on innovative RNAi-based therapeutics using sshRNA molecules, and diagnostics/biomarker detection (NGS, quantitative PCR) of small or fragmented RNA, including microRNA. Established in 1997, SomaGenics operates within the Biotechnology, Health and Wellness, and Construction industries. The company secured a noteworthy $1.80M grant investment on 04 October 2016 from the National Cancer Institute SBIR Development Center.
General Information
BounceWatch is an independent company data service, not affiliated with SomaGenics, Inc.. To contact SomaGenics, Inc., visit somagenics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About SomaGenics, Inc.
Taxonomy: Biotech, RNAi-based therapeutics, Diagnostics, Biomarker detection, NGS, Quantitative PCR, RNA-seq, Sequencing, Library Construction, Small RNAs, MicroRNAs, Small RNA technologies
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $1.80M | 1 |
National Cancer Institute SBIR Development Center
|
04 Oct 2016 |
SomaGenics, Inc. Alternatives & Competitors
Enabling Nucleic Acid Medicines for Next‑Generation Therapies | www.etherna.be
Artificial Intelligence, High Performance Computing, and RNA sequencing data to find cures faster th...
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift for neurod...
FAQ About SomaGenics, Inc.
Source: BounceWatch company record for SomaGenics, Inc., https://bouncewatch.com/company/somagenics-inc, updated 6 December 2024. When citing, please name BounceWatch and link this page.